Health Care Equipment & Services

Fresenius SE & Co. KGaA completes full acquisition of mAbxience, boosting its biopharma platform, enhancing biosimilar quality, and positioning for rapid market entry.

UnitedHealth Group’s robust market presence and strategic focus on value‑based care & digital transformation drive strong earnings, resilience and investor confidence.

Investigative analysis of Fresenius Medical Care AG short‑sale filings reveals modest investor concerns amid regulatory shifts, margin compression risks, and untapped growth in digital health and emerging markets.

Neuova Holding AG appoints Joe Ghiz and Shannon Basham to lead global expansion of its tinnitus‑treatment device, boosting market reach, reimbursement deals and patient access.

Philips beats market volatility, boosting digital health with AI imaging and connected care, driving 7.2% revenue growth while keeping debt low and cash flow strong.

ResMed’s October 1, 2026 SEC filings reveal board changes, AI‑driven strategy, a Noctrix Health acquisition, and shareholder‑value moves.

Fresenius SE completes full takeover of mAbxience, gaining 100% control over its biosimilar platform and boosting affordable biologic access.

UnitedHealth unveils 2027 Medicare Advantage plans with zero‑premium options, tighter networks and UCard security upgrades, reshaping senior coverage amid rising costs and a new CalPERS lawsuit.

Boston Scientific shows steady growth with disciplined capital use, deep R&D in cardiology & neurovascular, and efficient supply‑chain boosts.

IDEXX Laboratories boosts veterinary care with its CoVetAI AI scribe acquisition, enhancing diagnostics, workflow efficiency, and revenue potential.